AN2 Therapeutics, Inc., 2026-03-25
An SEC Form D private-offering notice from Menlo Park, CA, a $39,999,989 filer-stated offering target in Biotech. Filed 2026-03-25. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing therapies for rare, chronic and serious infectious diseases using a boron chemistry platform
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Adversarial Company, Inc., 2026-03-25, $1.5M, North Hollywood, CA
- Nok Therapeutics, Inc., 2026-03-26, $3K, Cranberry Twp., PA
- AlphaLitigation Inc., 2026-03-25, $4M, Covina, CA
- Jabez Biosciences, Inc., 2026-03-26, Cranberry Twp., PA
- ViaVia Corp, 2026-03-25, $30.1M, West Hollywood, CA
- 3X Genetics Inc., 2026-03-25, $4M, Worcester, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.